Chapter 3: Manufactured Fate
Hospital security found no intruder.
The photograph of Milo came from a camera built into his room’s patient tablet. Someone had accessed it through a remote support account used by Arden Biotech, the company supplying cardiac monitoring software.
Lyra preserved the access log before the hospital reset the system. Cassian wanted Wolfe security placed outside Milo’s room.
“One guard selected by me,” Lyra said. “Hospital credentials only. No pack insignia.”
“The threat concerns my succession agreement.”
“The patient is my brother.”
Cassian’s Alpha scent sharpened. Lyra’s omega instinct responded with unwanted awareness, but she did not mistake biology for authority.
“Choose the guard,” he said. “Wolfe Holdings pays under the security clause.”
Milo approved the plan after interviewing three candidates by video. He selected a quiet former paramedic named Imani Cole and rejected the largest man because he kept answering Lyra’s questions instead of Milo’s.
“Good risk assessment,” Lyra told him.
“I learned from the terrifying actuary who adopted me.”
With surgery still scheduled, Lyra attended the fertility examination at Northstar Reproductive Center. Nia met her in reception carrying an encrypted recorder and a consent checklist.
Dr. Owen Pike directed the program. He greeted Cassian by title and Lyra by first name.
“The compatibility screening is routine,” he said. “Blood, scent response, hormone profile, and genetic sequence.”
“Raw data goes simultaneously to Dr. Sol,” Lyra said.
“Our software issues a proprietary compatibility score.”
“The contract requires underlying measurements.”
Pike glanced at Cassian, expecting him to resolve the inconvenience.
“Send the data,” Cassian said.
The exam separated them into adjoining rooms. Lyra consented to blood draw and noninvasive scent testing. She refused an internal procedure Pike had added without explanation. Nia confirmed it was unnecessary before conception planning.
“Most candidates prefer a complete assessment,” Pike said.
“Then most candidates can choose it after accurate information.”
Pike removed the item from the form.
Cassian’s testing took twenty minutes. When he entered the shared consultation room, his expression revealed nothing. The clinic’s screen displayed a compatibility score of 97.8 percent—exceptionally high, consistent with a fated match.
Lyra felt the supposed bond as warmth beneath her skin. Cassian’s scent filled the room. Her pulse accelerated.
Pike smiled. “The result explains why the succession algorithm selected Ms. Dane.”
“I applied through a compensated-candidate listing,” Lyra said. “No algorithm contacted me.”
“Your profile was prioritized after application.”
Nia studied the raw feed on her tablet. “These scent-marker values are impossible.”
Pike stopped smiling.
Nia rotated the screen. Natural mate markers fluctuated across repeated samples. Lyra’s three tests showed identical values to six decimal places. Cassian’s results contained the same pattern with a fixed multiplier.
“They were generated from a template,” Lyra said.
“Or calibrated,” Pike replied.
“Calibration does not make human biology repeat exactly.”
Nia compared the lab timestamp with the draw record. The compatibility result existed eleven minutes before the final blood vial entered the analyzer.
Cassian’s wolf pressed close to the surface. “Run it again.”
Pike ordered a second test. Nia required a new technician, sealed reagents, and split samples sent to an independent laboratory. The Northstar system again produced 97.8 percent.
The independent rapid assay showed no exceptional mate-marker response.
Lyra’s attraction to Cassian remained. It no longer looked like fate. It looked like chemistry surrounded by manufactured numbers.
“Who selected me?” she asked.
Pike opened the candidate record. The referral field listed Arden Family Foundation, chaired by Celeste Arden.
Cassian went still. “Celeste was not supposed to return until after the merger.”
“She did not need to return to manipulate a database,” Lyra said.
Pike reached for the keyboard. Nia blocked his hand. “The record is under dispute. Do not alter it.”
Lyra photographed the screen with the audit code visible. Cassian called corporate security and ordered a forensic hold on every fertility-program system funded by Wolfe Holdings.
Pike protested that patient privacy prohibited corporate seizure.
“Correct,” Lyra said. “Security preserves servers. Independent medical custodians review patient data under court order.”
Cassian amended his instruction immediately.
Nia generated separate evidence copies before anyone disconnected the machines. Each file received a hash, timestamp, device identifier, and witness signature. The clinic retained its clinical record; Nia held Lyra’s copy; Cassian’s physician held his. No corporate lawyer received raw reproductive data.
The medical custodian imaged system logs under a neutral protocol. Search terms covered compatibility templates, candidate referrals, administrative changes, and billing codes while excluding unrelated patients’ identities. If suspicious patterns appeared, the clinic would notify affected patients through an independent advocate before Wolfe executives learned names.
Pike objected that the process implied guilt. Nia answered that preservation implied only that changing data later would become detectable.
Lyra requested the clinic’s informed-consent materials for prior candidates. Pike supplied a glossy brochure promising scientifically confirmed mate compatibility but no explanation of false-positive rates, financial sponsorship, or algorithmic selection. Even if her own result were the only altered record, the disclosure system was already inadequate.
Cassian read the brochure twice. “Wolfe Holdings funded this program.”
“Funding does not make you every clinician,” Lyra said. “It does make governance your responsibility.”
He ordered an immediate pause on new recruitment, subject to medical continuity for patients already in treatment. Lyra corrected his first draft so no patient lost medication or follow-up because executives wanted a clean announcement.
The clinic issued no clearance for treatment. Under the contract, no conception cycle could begin until both independent physicians approved.
In the corridor, Cassian asked whether Lyra planned to withdraw.
“Milo’s surgery funding is protected.”
“Yes.”
“Then I decide after the audit.”
“The merger deadline is in twelve days.”
“Your deadline does not change my biology.”
His frustration struck the air, but he nodded.
Nia’s tablet chimed. Northstar had replaced the candidate record during their conversation. The visible referral now said SELF-APPLICANT. Audit history showed no change.
Someone with administrator authority had erased the prior version.
Pike stood at the far end of the corridor holding his phone.
When he saw them looking, he slid it into his pocket.
The false result had not been a clerical error.
Dr. Pike was hiding who manufactured their fate.